Zdrowie i gospodarka · 15/06/1998

FDA Announces Approval of Abbreviated New Drug Application Regulations

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to Abbreviated New Drug Application Regulations, Patent and Exclusivity Provision, under the Paperwork Reduction Act of 1995 (PRA).